<html>
<head>
    <script language="JavaScript" src="http://code.jquery.com/jquery-1.4.4.js"></script>
    <script language="JavaScript" src="../js/pie.js"></script>
    <script language="JavaScript" src="../js/browser_adjust.js"></script>
    <script language="JavaScript" src="../js/search.js"></script>


    <script type="text/JavaScript">
    <!--

    var array = [[8.5436674519, "../topics/{product,_candidate,_development}.html", "{product,_candidate,_development}"], [1.8183358383, "../topics/{customer,_product,_revenue}.html", "{customer,_product,_revenue}"], [1.696777931, "../topics/{product,_market,_service}.html", "{product,_market,_service}"], [1.6963588897, "../topics/{debt,_indebtedness,_cash}.html", "{debt,_indebtedness,_cash}"], [1.6962664658, "../topics/{capital,_credit,_financial}.html", "{capital,_credit,_financial}"], [1.6962645803, "../topics/{stock,_price,_operating}.html", "{stock,_price,_operating}"], [1.6962626771, "../topics/{stock,_price,_share}.html", "{stock,_price,_share}"], [1.6962623509, "../topics/{personnel,_key,_retain}.html", "{personnel,_key,_retain}"], [1.6961668564, "../topics/{investment,_property,_distribution}.html", "{investment,_property,_distribution}"], [1.6951353485, "../topics/{acquisition,_growth,_future}.html", "{acquisition,_growth,_future}"], [1.6788163688, "../topics/{property,_intellectual,_protect}.html", "{property,_intellectual,_protect}"]];
    var elements = generate_pie_elements(array);
    var piec = null;
    function init() {
        browser_adjust();
        
        // create pie chart
        piec = new PieChart(elements);
        piec.initialize();

    }

    function highlight(i) {
        piec.highlight(i);
    }
    
    function unhighlight() {
        piec.unhighlight();
    }
    //-->
    </script>

    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    
    <title>895051--3/13/2009--ENTREMED_INC</title>

    <link href="../styling.css" rel="stylesheet" type="text/css">
</head>

<body onLoad="init()">
<div id="navigation">
<hr noshade>
<table><tr>
    <td class="navtext">Browse&nbsp;&#x25B8;</td> 
    <td class="linked"><a>Topics</a>
      <ul> 
        <li><a href="../browse/topic-list.html">List of Terms</a></li> 
        <li><a href="../browse/topic-graph.html">Term Distributions</a></li> 
        <li><a href="../browse/topic-presence.html">Relative Presence</a></li>
      </ul> 
    </td> 
    <td class="linked"><a>Documents</a>
      <ul>
        <li><a href="../browse/doc-graph.html">Topic Distributions</a></li>
      </ul> 
    </td>
    <td class="linked"><a>Terms</a>
      <ul> 
        <li><a href="../browse/term-list.html">List by Frequency</a></li> 
        <li><a href="../browse/term-graph.html">Topic Distributions</a></li> 
       </ul> 
    </td>
    <td class="linked"><a>About</a>
      <ul>
        <li><a href="http://www.cs.princeton.edu/~blei/lda-c/">LDA</a></li>
      </ul> 
    </td>
    
    </td>
    <td></td>
    <td class="searchbar"> Search&nbsp;&#x25B8;</td>
    <td class="searchbar"><input type="text" name="search" size="20" onkeypress="handleKeyPress(event)"><span onclick="doSearch()"></span>
    </td>
</tr></table>
</div>

    <div id="top"></div>

    <h1 id="header">
        <table><tr>
            <td id="title">895051--3/13/2009--ENTREMED_INC</td>
        </tr></table>

        <hr noshade>
    </h1>

    <div id="main">
        <table><tr>
            <td width="210px">
                <table class="dark">
                <tr><td><canvas id="canvas" width="200" height="200"></canvas></td></tr>
                <tr class="title">
                    <td>related topics</td>
                </tr>
                <tr class="list"><td id="{product,_candidate,_development}" onmouseover="highlight(0)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_candidate,_development}.html'">{product, candidate, development}</td></tr>
<tr class="list"><td id="{customer,_product,_revenue}" onmouseover="highlight(1)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{customer,_product,_revenue}.html'">{customer, product, revenue}</td></tr>
<tr class="list"><td id="{product,_market,_service}" onmouseover="highlight(2)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_market,_service}.html'">{product, market, service}</td></tr>
<tr class="list"><td id="{debt,_indebtedness,_cash}" onmouseover="highlight(3)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{debt,_indebtedness,_cash}.html'">{debt, indebtedness, cash}</td></tr>
<tr class="list"><td id="{capital,_credit,_financial}" onmouseover="highlight(4)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{capital,_credit,_financial}.html'">{capital, credit, financial}</td></tr>
<tr class="list"><td id="{stock,_price,_operating}" onmouseover="highlight(5)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{stock,_price,_operating}.html'">{stock, price, operating}</td></tr>
<tr class="list"><td id="{stock,_price,_share}" onmouseover="highlight(6)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{stock,_price,_share}.html'">{stock, price, share}</td></tr>
<tr class="list"><td id="{personnel,_key,_retain}" onmouseover="highlight(7)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{personnel,_key,_retain}.html'">{personnel, key, retain}</td></tr>
<tr class="list"><td id="{investment,_property,_distribution}" onmouseover="highlight(8)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{investment,_property,_distribution}.html'">{investment, property, distribution}</td></tr>
<tr class="list"><td id="{acquisition,_growth,_future}" onmouseover="highlight(9)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{acquisition,_growth,_future}.html'">{acquisition, growth, future}</td></tr>
<tr class="list"><td id="{property,_intellectual,_protect}" onmouseover="highlight(10)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{property,_intellectual,_protect}.html'">{property, intellectual, protect}</td></tr>

                </table>
            </td>

            <td>
                <table class="light">
                <tr class="doc"><td>
                    The Current Capital and Credit Market Conditions May Adversely Affect the Company s Access to Capital, Cost of Capital, and Ability to Execute its Business Plan as Scheduled
We Rely Exclusively on the Royalty Payments Based upon Thalomid Sales by a Third-Party to Produce our Revenues
Our Common Stock May be Delisted From The NASDAQ Capital Market, Which Could Negatively Impact the Price of Our Common Stock and Our Ability to Access the Capital Markets
The Market Price of Our Common Stock May Be Highly Volatile or May Decline Regardless of Our Operating Performance
Our Existing Term Loan Contains Affirmative and Negative Covenants That May Restrict our Business and Financing Activities
Our Secured Lender and Preferred Stockholder Would Have Priority in Distributions Over our Common Stockholders Following a Liquidation Event Affecting the Company. As a Result, in the Event of a Liquidation Event, our Common Stockholders Would Receive Distributions Only After Priority Distributions Are Paid
Development of Our Products is at an Early Stage and is Uncertain
Technological Developments By Competitors May Render Our Products Obsolete
We are Uncertain Whether Additional Funding Will Be Available For Our Future Capital Needs and Commitments, and If We Cannot Raise Additional Funding, or Access the Credit Markets, We May Be Unable to Complete Development of Our Product Candidates
We Must Show the Safety and Efficacy of Our Product Candidates Through Clinical Trials, the Results of Which are Uncertain
The Independent Clinical Investigators and Contract Research Organizations That We Rely Upon to Assist in the Conduct of Our Clinical Trials May Not Be Diligent, Careful or Timely, and May Make Mistakes, in the Conduct of Our Trials
The Success of Our Business Depends Upon the Members of Our Senior Management Team, Our Scientific Staff and Our Ability to Continue to Attract and Retain Qualified Scientific, Technical and Business Personnel
We May Need New Collaborative Partners to Further Develop and Commercialize Products, and if We Enter Into Such Arrangements, We May Give Up Control Over the Development and Approval Process and Decrease our Potential Revenue
We Have No Current Manufacturing or Marketing Capacity and Rely on Only One Supplier For Some of Our Products
Failure of Manufacturing Facilities Producing Our Product Candidates to Maintain Regulatory Approval Could Delay or Otherwise Hinder Our Ability to Market Our Product Candidates
Manufacturing Our Product Candidates May Not Be Commercially Feasible
We Depend on Patents and Other Proprietary Rights, Some of Which are Uncertain
Our Potential Products Are Subject to Government Regulatory Requirements and an Extensive Approval Process
<p><a href="http://www.sec.gov/Archives/edgar/data/895051/0000950133-09-000720.txt">Full 10-K form&nbsp;&#x25B8;</a></p>
                </td></tr>
                </table>
            </td>

            <td width="25%">
                <table class="dark">
                <tr class="title">
                    <td>related documents</td>
                </tr>
                <tr class="list"><td onclick="window.location.href='../docs/805326--3-25-2010--EMISPHERE_TECHNOLOGIES_INC.html'">805326--3/25/2010--EMISPHERE_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/805326--3-16-2009--EMISPHERE_TECHNOLOGIES_INC.html'">805326--3/16/2009--EMISPHERE_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/818033--3-31-2006--AP_PHARMA_INC_-DE-.html'">818033--3/31/2006--AP_PHARMA_INC_/DE/</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/805326--3-6-2007--EMISPHERE_TECHNOLOGIES_INC.html'">805326--3/6/2007--EMISPHERE_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1005201--3-16-2006--DEPOMED_INC.html'">1005201--3/16/2006--DEPOMED_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/882796--3-9-2010--BIOCRYST_PHARMACEUTICALS_INC.html'">882796--3/9/2010--BIOCRYST_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/819050--2-23-2007--VICAL_INC.html'">819050--2/23/2007--VICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/64978--3-30-2010--MERCK_SHARP_&_DOHME_CORP..html'">64978--3/30/2010--MERCK_SHARP_&_DOHME_CORP.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/887151--3-13-2006--ORTHOLOGIC_CORP.html'">887151--3/13/2006--ORTHOLOGIC_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/819050--3-10-2006--VICAL_INC.html'">819050--3/10/2006--VICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1066833--3-15-2006--DOV_PHARMACEUTICAL_INC.html'">1066833--3/15/2006--DOV_PHARMACEUTICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1033025--3-17-2006--PRAECIS_PHARMACEUTICALS_INC.html'">1033025--3/17/2006--PRAECIS_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1123979--2-4-2010--SENOMYX_INC.html'">1123979--2/4/2010--SENOMYX_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/799698--4-3-2006--CYTRX_CORP.html'">799698--4/3/2006--CYTRX_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1140028--3-16-2006--Hana_Biosciences_Inc.html'">1140028--3/16/2006--Hana_Biosciences_Inc</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1123979--2-12-2009--SENOMYX_INC.html'">1123979--2/12/2009--SENOMYX_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1029142--3-16-2007--DYNAVAX_TECHNOLOGIES_CORP.html'">1029142--3/16/2007--DYNAVAX_TECHNOLOGIES_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1029142--3-16-2006--DYNAVAX_TECHNOLOGIES_CORP.html'">1029142--3/16/2006--DYNAVAX_TECHNOLOGIES_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/819050--3-3-2008--VICAL_INC.html'">819050--3/3/2008--VICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/819050--3-3-2009--VICAL_INC.html'">819050--3/3/2009--VICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/819050--2-25-2010--VICAL_INC.html'">819050--2/25/2010--VICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/882796--3-6-2009--BIOCRYST_PHARMACEUTICALS_INC.html'">882796--3/6/2009--BIOCRYST_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/882796--3-4-2008--BIOCRYST_PHARMACEUTICALS_INC.html'">882796--3/4/2008--BIOCRYST_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/919745--3-16-2007--POINT_THERAPEUTICS_INC.html'">919745--3/16/2007--POINT_THERAPEUTICS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/730272--6-9-2006--REPLIGEN_CORP.html'">730272--6/9/2006--REPLIGEN_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1162192--3-31-2009--AVALON_PHARMACEUTICALS_INC.html'">1162192--3/31/2009--AVALON_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/907562--3-4-2009--DYAX_CORP.html'">907562--3/4/2009--DYAX_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/318154--3-10-2006--AMGEN_INC.html'">318154--3/10/2006--AMGEN_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/824068--3-14-2008--ATS_MEDICAL_INC.html'">824068--3/14/2008--ATS_MEDICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1396238--3-31-2010--IRIS_BIOTECHNOLOGIES_INC.html'">1396238--3/31/2010--IRIS_BIOTECHNOLOGIES_INC</td></tr>

                </table>
            </td>
        </tr></table>
    </div>

    <div id="footer">
        <br>
        <hr noshade>
    </div>
</body>
</html>
